SON; Eun Jung

Patent Applications and Registrations

Patent applications and USPTO patent grants for SON; Eun Jung.The latest application filed is for "composition for preventing, ameliorating, or treating respiratory disease comprising siraitia grosvenorii extract as effective component".

Company Profile

2.10.12

SON; Eun Jung - Sejong-si KR
Son; Eun Jung - Chungcheongnam-do N/A KR
Son; Eun Jung - Yongin-si N/A KR
Son; Eun-Jung - Beltsville MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition For Preventing, Ameliorating, Or Treating Respiratory Disease Comprising Siraitia Grosvenorii Extract As Effective Component App 20210138012 - KIM; Dong Seon ; et al.	2021-05-13
Composition For Prevention, Improvement Or Treatment Of Osteoarthritis Comprising Alpinia Oxyphylla Extract As Effective Compone App 20200268827 - KIM; Dong Seon ; et al.	2020-08-27
Composition for preventing, ameliorating, or treating hyperuricemia or metabolic disorders related with hyperuricemia comprising extract of Alpinia oxyphylla as effective ingredient Grant 10,709,754 - Kim , et al.	2020-07-14
Composition For Preventing, Ameliorating, Or Treating Hyperuricemia Or Metabolic Disorders Related With Hyperuricemia Comprising Extract Of Alpinia Oxyphylla As Effective Ingredient App 20190099465 - KIM; Dong Seon ; et al.	2019-04-04
Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria Grant 8,771,761 - Woo , et al. July 8, 2	2014-07-08
Thiazole derivatives as SGLT2 inhibitors and pharmaceutical composition comprising same Grant 8,586,550 - Lee , et al. November 19, 2	2013-11-19
C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same Grant 8,541,380 - Lee , et al. September 24, 2	2013-09-24
Thiazole Derivatives as SGLT2 Inhibitors and Pharmaceutical Composition Comprising Same App 20130090298 - Lee; Jinhwa ; et al.	2013-04-11
Composition For Treating Atopic Dermatitis Comprising Extracts Of Bamboo And Scutellaria App 20130064910 - Woo; Sung Sick ; et al.	2013-03-14
Composition for treating atopic dermatitis comprising extracts of bamboo and Scutellaria Grant 8,247,007 - Woo , et al. August 21, 2	2012-08-21
Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for Parkinson'S disease prevention or treatment Grant 8,178,551 - Lee , et al. May 15, 2	2012-05-15
Novel C-aryl Glucoside Sglt2 Inhibitors And Pharmaceutical Compositions Comprising Same App 20120101051 - Lee; Jinhwa ; et al.	2012-04-26
Orally Bioavailable Products Of (+)-3-hydroxymorphinan For Parkinson's Disease Prevention Or Treatment App 20100113500 - Lee; Jinhwa ; et al.	2010-05-06
Composition For Treating Atopic Dermatitis Comprising Extracts Of Bamboo And Scutellaria App 20100015257 - Woo; Sung Sick ; et al.	2010-01-21
Azole Derivatives as Cannabinoid CB1 Receptor Antagonists App 20080262066 - LEE; Jinhwa ; et al.	2008-10-23
Recombinant scFV antibodies specific to Eimeria spp. responsible for coccidiosis Grant 6,790,937 - Kim , et al. September 14, 2	2004-09-14
Recombinant scFV antibodies specific to Eimeria spp. responsible for coccidiosis App 20030104497 - Kim, Jin-Kyoo ; et al.	2003-06-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.